Last reviewed · How we verify
BI 894999
At a glance
| Generic name | BI 894999 |
|---|---|
| Sponsor | Boehringer Ingelheim |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
- Fatigue
- Cough
- Toothache
- Chest pain
- Pyrexia
- Decreased appetite
- Hypophosphataemia
- Arthralgia
- Dysgeusia
- Dyspnoea
- Erythema
- Hypertension
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BI 894999 CI brief — competitive landscape report
- BI 894999 updates RSS · CI watch RSS
- Boehringer Ingelheim portfolio CI